Skip to main content

Inside the world’s largest art heist when over $500M of paintings were stolen from a Boston museum

BOSTON (AP) — For decades, the 1990 theft of 13 artworks from the Isabella Stewart Gardner Museum — now valued at more than $500 million — has remained unsolved.

It remains the largest art theft in history — far surpassing more recent museum thefts, including a daylight heist at the Louvre involving far fewer works that was resolved more quickly. In 2013, the FBI said it knew who was responsible for the Boston museum heist but declined to name them, fueling speculation that persists today.

A former FBI agent who led the investigation for more than two decades is now offering the first detailed account of how investigators reached that conclusion — and publicly identifying the men he believes were involved. In a new book, “Thirteen Perfect Fugitives,” Geoffrey Kelly traces how the artworks moved through criminal networks, where violence took the lives of key suspects and witnesses, and challenges long-circulating theories by revisiting key details.

The irony at the center is Gardner’s intention for the museum to remain frozen in time, stipulating in her will that nothing in the Venetian palazzo-inspired building would be changed after her death. Gardner, who lived in the museum and died there in 1924, intended for the paintings, sculptures and architectural fragments to remain exactly as she had arranged.

The empty gilded frames of the missing paintings still hang in the museum today — silent witnesses to what was taken.

The art heist

Early on March 18, 1990, as Boston wound down from St. Patrick’s Day celebrations, two men dressed as police officers arrived at the museum and persuaded a security guard to let them in, violating protocol.

The men handcuffed the guards in the basement and made their way to the museum’s Dutch Room, where they cut Vermeer’s “The Concert” and Rembrandt’s “Christ in the Storm on the Sea of Galilee” from their frames, also taking works by Degas and Manet.

They also took a Napoleonic eagle finial — a decorative metal piece of comparatively little value that investigators later found puzzling — and the museum’s security videotapes.

The museum offered a $5 million reward that they then doubled a decade later for information leading to the recovery of the works.

Boston-area network of criminals

Some tips pointed to the Irish Republican Army and to Boston mob figures, including notorious crime boss Whitey Bulger.

Kelly followed one lead to France, where he watched through binoculars as FBI agents, posing as wealthy intermediaries, lounged on a yacht — drinking Champagne and eating strawberries — in an effort to draw out suspected Corsican mob figures.

Closer to home, agents searched houses across New England, relying heavily on informants. A triple murderer known as “Meatball” who was terminally ill secretly recorded conversations with suspected associates in hopes of earning money for his family.

But none of the tips led to the paintings.

Violence complicates matters

In the decades since the robbery, several people believed to have ties to the heist were killed, and another died under suspicious circumstances.

Robert “Bobby” Donati, a Boston mob associate long suspected in the case, was found stabbed to death in 1991, his body left in the trunk of a car after his home had been ransacked.

Years earlier, Donati visited the Gardner with another known art thief, Myles Connor, to scope it out for a robbery and said that if he ever took the museum’s Napoleonic finial, it would be his “calling card.” Years later, a jeweler told investigators Donati tried to sell a finial but the jeweler declined, saying it was “too hot.”

A separate line of evidence centered on George Reissfelder, who investigators believe owned the getaway car.

Kelly tracked down Reissfelder’s brother, a retired military officer who had initially not believed his brother was involved. He broke down after being shown Manet’s “Chez Tortoni,” saying he recognized it as a painting he himself hung above his brother’s bed.

Reissfelder later died under suspicious circumstances. When investigators searched his home, the painting was gone.

Both men had ties to TRC Auto Electric, a Dorchester shop linked to Charles “Chuck” Merlino’s crew.

Investigation with limited resources

Though investigators believed they knew who was responsible, they had a difficult time finding definitive proof.

In the investigation’s early stages, the FBI assigned a single agent to the case, which Kelly said slowed progress.

“You have to keep in mind when you’re talking about investigations, they come down to dollars and cents,” Kelly said. It was “like pulling teeth” to secure resources. At the time, federal investigators in Boston were heavily focused on violent crime, drug trafficking and organized crime cases.

Kelly said a decision to release surveillance footage despite investigators’ objections became a lasting distraction. With no usable video from the night of the robbery, prosecutors released footage from the night before that showed a museum employee entering the building after his car broke down. Kelly said he objected to the theory that the employee was casing the museum, since that possibility had already been reviewed and dismissed. The footage fueled years of misplaced suspicion; the man was later determined not to have been involved.

Despite those challenges, Kelly credited supervisors who pushed to give the museum’s security director access to the case so investigators could share leads — a rare level of collaboration — and said earlier investigators left extensive notes, first in paper binders and then later transferred to CDs.

Theories about an inside job at the museum

In photos from that night, a museum guard is seen handcuffed in the basement, his head wrapped in duct tape.

Investigators noted that shortly before the robbery, the guard opened a door against policy — one that faced the area where the thieves were later seen waiting — a move investigators considered highly unusual and suspicious.

“It’s the immutable laws of time and space,” Kelly said. “I think that there was enough information back then that he could have been charged. Would it be enough to convict him? I don’t know.”

By the time investigators examined those questions more closely, Kelly said, the statute of limitations had expired, leaving them with little leverage to compel cooperation.

The museum guard, Rick Abath, denied any involvement in the theft. He died in 2024.

The artworks that disappeared

Kelly personifies the missing artworks and describes them as “perfect fugitives.”

“They don’t go to the doctor. They don’t get stopped for speeding. They don’t leave fingerprints,” he said. “They can just disappear.”

Unlike human fugitives, he said, artworks can also be copied.

Over the years, that has meant chasing down false leads — including paintings spotted in a Reno antique market, hanging in private homes and even one that appeared in an episode of the TV show “Monk.”

Because the works are so recognizable, it’s nearly impossible to sell them publicly.

“Stealing the artwork from the museum, that’s the easy part,” Kelly said. “Profiting from it, that’s the difficult part.”

He imagines the paintings will surface one day — outliving those who carried out the heist.

“I have no doubt they still exist,” he said

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story